These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10227098)

  • 61. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.
    Le Loët X; Berthelot JM; Cantagrel A; Combe B; De Bandt M; Fautrel B; Flipo RM; Lioté F; Maillefert JF; Meyer O; Saraux A; Wendling D; Guillemin F
    Ann Rheum Dis; 2006 Jan; 65(1):45-50. PubMed ID: 15994280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
    Kuijper TM; Lamers-Karnebeek FB; Jacobs JW; Hazes JM; Luime JJ
    J Rheumatol; 2015 Nov; 42(11):2012-22. PubMed ID: 26428204
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
    Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
    J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current concepts in the management of rheumatoid arthritis.
    Tanaka Y
    Korean J Intern Med; 2016 Mar; 31(2):210-8. PubMed ID: 26932398
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The importance of early treatment for the prognosis of rheumatoid arthritis.
    Kyburz D; Finckh A
    Swiss Med Wkly; 2013; 143():w13865. PubMed ID: 24089023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Disease Characteristics and Rheumatoid Arthritis Development in Patients with Early Undifferentiated Arthritis: A 2-year Followup Study.
    Brinkmann GH; Norli ES; Kvien TK; Haugen AJ; Grøvle L; Nygaard H; Bjørneboe O; Thunem C; Mjaavatten MD; Lie E
    J Rheumatol; 2017 Feb; 44(2):154-161. PubMed ID: 28089976
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 69. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis).
    Lukas C; Combe B; Ravaud P; Sibilia J; Landew R; van der Heijde D
    Arthritis Rheum; 2011 Jul; 63(7):1804-11. PubMed ID: 21452295
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pharmacotherapy of rheumatoid arthritis].
    Gromnica-Ihle E
    Z Rheumatol; 2002; 61 Suppl 2():II/35-8. PubMed ID: 12491122
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emerging treatments for rheumatoid arthritis.
    Schiff M
    Am J Med; 1997 Jan; 102(1A):11S-15S. PubMed ID: 9217554
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effects of therapy on functional ability of patients with rheumatoid arthritis].
    Kapidzić-Basić N; Selesković H; Mulić S
    Med Arh; 2007; 61(3):164-8. PubMed ID: 18232281
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term outcome of rheumatoid arthritis defined according to the 2010-classification criteria.
    Burgers LE; van Nies JA; Ho LY; de Rooy DP; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2014 Feb; 73(2):428-32. PubMed ID: 23661495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Summary of the practice guideline 'Rheumatoid arthritis' (first revision) from the Dutch College of General Practitioners].
    Wiersma T; Flikweert S; van den Bosch WJ;
    Ned Tijdschr Geneeskd; 2004 Mar; 148(12):559-64. PubMed ID: 15074177
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy.
    Feehan LM; Li LL; McKay HA
    BMC Musculoskelet Disord; 2017 Dec; 18(1):521. PubMed ID: 29228959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of rheumatoid arthritis. New thoughts on the classic pyramid approach.
    Schenkier S; Golbus J
    Postgrad Med; 1992 Jan; 91(1):285-6, 289-92. PubMed ID: 1345881
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.